BACKGROUND: Acute lung injury is characterized by hypercoagulability and impaired fibrinolysis. We hypothesized that lower protein C and higher type 1 plasminogen activator inhibitor (PAI-1) levels in plasma would be associated with primary graft dysfunction (PGD) after lung transplantation. DESIGN: Prospective, multicenter cohort study. METHODS: We measured plasma levels of protein C and PAI-1 before lung transplantation and 6, 24, 48, and 72 h after allograft reperfusion in 128 lung transplant recipients at six centers. The primary outcome was grade 3 PGD (Pa(O(2))/Fi(O(2)) < 200 with alveolar infiltrates) 72 h after transplantation. Biomarker profiles were evaluated using logistic regression and generalized estimating equations. RESULTS: Patients who developed PGD had lower protein C levels 24 h posttransplantation than did patients without PGD (mean +/- SD [relative to control]: 64 +/- 27 vs. 92 +/- 41%, respectively; p = 0.002). Patients with PGD also had PAI-1 levels that were almost double those of patients without PGD at 24 h (213 +/- 144 vs. 117 +/- 89 ng/ml, respectively; p < 0.001). Throughout the 72-h postoperative period, protein C levels were significantly lower (p = 0.007) and PAI-1 levels were higher (p = 0.026) in subjects with PGD than in others. These differences persisted despite adjustment for potential confounders in multivariate analyses. Higher recipient pulmonary artery pressures, measured immediately pretransplantation, were associated with higher PAI-1 levels and increased risk of PGD. CONCLUSION: Lower postoperative protein C and higher PAI-1 plasma levels are associated with PGD after lung transplantation. Impaired fibrinolysis and enhanced coagulation may be important in PGD pathogenesis.
BACKGROUND: Acute lung injury is characterized by hypercoagulability and impaired fibrinolysis. We hypothesized that lower protein C and higher type 1 plasminogen activator inhibitor (PAI-1) levels in plasma would be associated with primary graft dysfunction (PGD) after lung transplantation. DESIGN: Prospective, multicenter cohort study. METHODS: We measured plasma levels of protein C and PAI-1 before lung transplantation and 6, 24, 48, and 72 h after allograft reperfusion in 128 lung transplant recipients at six centers. The primary outcome was grade 3 PGD (Pa(O(2))/Fi(O(2)) < 200 with alveolar infiltrates) 72 h after transplantation. Biomarker profiles were evaluated using logistic regression and generalized estimating equations. RESULTS:Patients who developed PGD had lower protein C levels 24 h posttransplantation than did patients without PGD (mean +/- SD [relative to control]: 64 +/- 27 vs. 92 +/- 41%, respectively; p = 0.002). Patients with PGD also had PAI-1 levels that were almost double those of patients without PGD at 24 h (213 +/- 144 vs. 117 +/- 89 ng/ml, respectively; p < 0.001). Throughout the 72-h postoperative period, protein C levels were significantly lower (p = 0.007) and PAI-1 levels were higher (p = 0.026) in subjects with PGD than in others. These differences persisted despite adjustment for potential confounders in multivariate analyses. Higher recipient pulmonary artery pressures, measured immediately pretransplantation, were associated with higher PAI-1 levels and increased risk of PGD. CONCLUSION: Lower postoperative protein C and higher PAI-1 plasma levels are associated with PGD after lung transplantation. Impaired fibrinolysis and enhanced coagulation may be important in PGD pathogenesis.
Authors: Thomas J Nuckton; James A Alonso; Richard H Kallet; Brian M Daniel; Jean-François Pittet; Mark D Eisner; Michael A Matthay Journal: N Engl J Med Date: 2002-04-25 Impact factor: 91.245
Authors: Selim M Arcasoy; Andrew Fisher; Ramsey R Hachem; Masina Scavuzzo; Lorraine B Ware Journal: J Heart Lung Transplant Date: 2005-10 Impact factor: 10.247
Authors: Marc De Perrot; Yasuo Sekine; Stefan Fischer; Thomas K Waddell; Karen McRae; Mingyao Liu; Dennis A Wigle; Shaf Keshavjee Journal: Am J Respir Crit Care Med Date: 2002-01-15 Impact factor: 21.405
Authors: Priya Prabhakaran; Lorraine B Ware; Kimberly E White; Michael T Cross; Michael A Matthay; Mitchell A Olman Journal: Am J Physiol Lung Cell Mol Physiol Date: 2003-05-02 Impact factor: 5.464
Authors: Jason D Christie; Robert M Kotloff; Alberto Pochettino; Selim M Arcasoy; Bruce R Rosengard; J Richard Landis; Stephen E Kimmel Journal: Chest Date: 2003-10 Impact factor: 9.410
Authors: R J Shah; J M Diamond; E Cantu; J Flesch; J C Lee; D J Lederer; V N Lama; J Orens; A Weinacker; D S Wilkes; D Roe; S Bhorade; K M Wille; L B Ware; S M Palmer; M Crespo; E Demissie; J Sonnet; A Shah; S M Kawut; S L Bellamy; A R Localio; J D Christie Journal: Am J Transplant Date: 2015-04-15 Impact factor: 8.086
Authors: R J Shah; N Wickersham; D J Lederer; S M Palmer; E Cantu; J M Diamond; S M Kawut; V N Lama; S Bhorade; M Crespo; E Demissie; J Sonett; K Wille; J Orens; A Weinacker; P Shah; S Arcasoy; D S Wilkes; J D Christie; L B Ware Journal: Am J Transplant Date: 2014-01-08 Impact factor: 8.086
Authors: J M Diamond; S M Kawut; D J Lederer; V N Ahya; B Kohl; J Sonett; S M Palmer; M Crespo; K Wille; V N Lama; P D Shah; J Orens; S Bhorade; A Weinacker; E Demissie; S Bellamy; J D Christie; L B Ware Journal: Am J Transplant Date: 2011-02-07 Impact factor: 8.086
Authors: Ciara M Shaver; Nancy Wickersham; J Brennan McNeil; Hiromasa Nagata; Adam Miller; Stuart R Landstreet; Jamie L Kuck; Joshua M Diamond; David J Lederer; Steven M Kawut; Scott M Palmer; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria M Crespo; Jonathan B Orens; Pali D Shah; Chadi A Hage; Edward Cantu; Mary K Porteous; Gundeep Dhillon; John McDyer; Julie A Bastarache; Jason D Christie; Lorraine B Ware Journal: JCI Insight Date: 2018-01-25
Authors: Michael W Sims; Michael F Beers; Vivek N Ahya; Steven M Kawut; Karen D Sims; David J Lederer; Scott M Palmer; Keith Wille; Vibha N Lama; Pali D Shah; Jonathan B Orens; Sangeeta Bhorade; Maria Crespo; Ann Weinacker; Ejigayehu Demissie; Scarlett Bellamy; Jason D Christie; Lorraine B Ware Journal: Chest Date: 2011-02-24 Impact factor: 9.410
Authors: David M Sayah; Beñat Mallavia; Fengchun Liu; Guadalupe Ortiz-Muñoz; Axelle Caudrillier; Ariss DerHovanessian; David J Ross; Joseph P Lynch; Rajan Saggar; Abbas Ardehali; Lorraine B Ware; Jason D Christie; John A Belperio; Mark R Looney Journal: Am J Respir Crit Care Med Date: 2015-02-15 Impact factor: 21.405
Authors: Joshua M Diamond; Tatiana Akimova; Altaf Kazi; Rupal J Shah; Edward Cantu; Rui Feng; Matthew H Levine; Steven M Kawut; Nuala J Meyer; James C Lee; Wayne W Hancock; Richard Aplenc; Lorraine B Ware; Scott M Palmer; Sangeeta Bhorade; Vibha N Lama; Ann Weinacker; Jonathan Orens; Keith Wille; Maria Crespo; David J Lederer; Selim Arcasoy; Ejigayehu Demissie; Jason D Christie Journal: Am J Respir Crit Care Med Date: 2014-03-01 Impact factor: 21.405
Authors: Barbara C S Hamilton; Gabriela R Dincheva; Hanjing Zhuo; Jeffrey A Golden; Marek Brzezinski; Jonathan P Singer; Michael A Matthay; Jasleen Kukreja Journal: Clin Transplant Date: 2018-02-23 Impact factor: 2.863